Go to Page # Page of 13
loading

Advanced Genetic Engineering of Hematopoiesis

 Pietro Genovese PhD
  16th-Aug-2019
Description: HSC Gene Therapy targeted insertion in a safe locus and genotoxic risk limited to off-target activity circumscribed to a small fraction of genome.
Views: 888
Domain: Medical
Category: Biotech/Pharma
Contents:
Advanced Genetic
Engineering of
Hematopoiesis for the
Treatment of Inherited
Diseases
Pietro Genovese, Ph.D.
Project Leader
San Raffaele Scientific Institute
Telethon Institute for Gene Therapy
Milan, Italy

Pietro.Genovese@hsr.it

Gene Editing Workshop
Washington DC
April 28th 2019

Therapeutic Potential of HSC Gene Therapy
Immuno-hematological diseases
Gene
Transfer

Infuse into
conditioned rec ... See more

Recent Presentations

ASPR Tracie Resources Overview 2019

The healthcare supply chain is confronted with many small to large daily challenges & under distinct strains during disasters. while HCC supply chain integrity self-assessment.

...
22 September, 2019
...
21 September, 2019
Yoojin Oh
20 September, 2019